Filtered By:
Specialty: Cardiology
Management: Expenditures

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 18 results found since Jan 2013.

Abstract 205: Stroke Risk and Symptom Recognition Post Cardiac Catheterization Session Title: Poster Session PM
Over 1.4 million cardiac catheterization procedures (CCPs) take place yearly. CPP related stroke incidence in 1973 was reported as 0.23%. CCPs are invasive in nature with complications occurring due to unintentional trauma to preexisting atherosclerotic aortic plaques or thrombus formation at catheter/guidewire tips. Less common causes of ischemic stroke are air, left ventricular clot, hypotension, arterial dissection, fractured guidewire. Transient neurological deficits have been reported following high-osmolar contrast injection into carotid/vertebral arteries. With improved practice, current stroke incidence is 0.06%. P...
Source: Circulation: Cardiovascular Quality and Outcomes - April 5, 2018 Category: Cardiology Authors: Rivet, C., Schaefer, K., Strom, C. Tags: Session Title: Poster Session PM Source Type: research

Shift work and risk of stroke: A meta-analysis
Stroke is one of the leading causes of mortality which is accounted for 11.8% of total deaths worldwide [1]. On average, every 4min, someone died of a stroke. Stroke accounted for ≈1 of every 20 deaths in the United States, with serious consequences for health care expenditure [2]. It has been estimated that the total direct medical expenditure on stroke is at least $71.6 billion in 2012 and will be $184.1 billion in 2030, this creates a major public health burden [3]. Moreover, approximately 10% of all strokes occur in individuals 18 to 50years of age, which is the main productivity [4].
Source: International Journal of Cardiology - March 29, 2016 Category: Cardiology Authors: Min Li, Jiang-tao Huang, Yuan Tan, Bao-ping Yang, Zhen-Yu Tang Tags: Correspondence Source Type: research

Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States.
Abstract Acute myocardial infarction (AMI) and stroke are unanticipated major healthcare events that require emergent and expensive care. Given the potential financial implications of AMI and stroke among uninsured patients, we sought to evaluate rates of catastrophic healthcare expenditures (CHEs), defined as expenses beyond financial means, in a period before the implementation of insurance expansion and protections in the Affordable Care Act.(1). PMID: 29133601 [PubMed - as supplied by publisher]
Source: Circulation - November 13, 2017 Category: Cardiology Authors: Khera R, Hong JC, Saxena A, Arrieta A, Virani SS, Blankstein R, de Lemos JA, Krumholz HM, Nasir K Tags: Circulation Source Type: research

Atrial Cardiopathy: Redefining Stroke Risk Beyond Atrial Fibrillation
Atrial fibrillation (AF) and ischemic stroke are dual epidemics in society, both associated with poor clinical outcomes, patient disability, and significant healthcare expenditure. The conditions are interrelated and share complex causal pathways. Risk stratification algorithms such as the CHADS2 and CHA2DS2-VASc score offer predictive value in stroke and systemic embolism risk in the AF population, however, have limitations. Recent evidence suggests that an intrinsically prothrombotic atrial substrate may precede and promote AF and lead to thromboembolic events independent of the arrhythmia, allowing for a window of inter...
Source: The American Journal of Cardiology - June 28, 2023 Category: Cardiology Authors: Jessica Chu Zhang, Aditya Bhat Source Type: research

Cardiovascular Disease in Asian Americans Unmasking Heterogeneity ∗
Heart disease is the leading cause of death in the United States, and stroke is the fourth leading cause of death (1). Together, heart disease and stroke accounted for more than $300 billion in health care expenditures and related expenses in 2010 alone (2). However, from 2000 to 2010, death rates attributable to cardiovascular disease (CVD) declined by 31.0%. In the same 10-year period, the actual number of annual deaths from CVD declined by 16.7% (2). Yet in 2010, CVD still accounted for 31.9% of all 2,468,435 deaths, or about 1 of every 3 deaths in the United States (2). Despite this decline, considerable data from th...
Source: Journal of the American College of Cardiology - December 8, 2014 Category: Cardiology Source Type: research

Methods of accelerated atherosclerosis in diabetic patients
This article will focus on the effect of diabetes on the initiation and progression of arterial occlusive disease, preceded by a short outline of the enormous impact of this issue from a societal-economic perspective. Diabetes, a major healthcare issue The prevalence and associated costs of diabetes are expected to increase significantly. There are currently over 240...
Source: Heart - April 18, 2013 Category: Cardiology Authors: Pasterkamp, G. Tags: Diabetic heart disease, Health policy, Education in Heart, Drugs: cardiovascular system, Hypertension, Acute coronary syndromes, Stable coronary heart disease, Epidemiology, Diabetes, Metabolic disorders Source Type: research

Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century
Abstract: Background: Atrial fibrillation (AF) represents an increasing public health challenge with profound social and economic implications.Methods: A comprehensive synthesis and review of the AF literature was performed. Overall, key findings from 182 studies were used to describe the indicative scope and impact of AF from an individual to population perspective.Results: There are many pathways to AF including advancing age, cardiovascular disease and increased levels of obesity/metabolic disorders. The reported population prevalence of AF ranges from 2.3%–3.4% and historical trends reflect increased AF incidence. Es...
Source: International Journal of Cardiology - February 4, 2013 Category: Cardiology Authors: Jocasta Ball, Melinda J. Carrington, John J.V. McMurray, Simon Stewart Tags: Reviews Source Type: research

Update on atrial fibrillation
Atrial fibrillation (AF) is the most common arrhythmia and accounts for one-third of hospitalizations for rhythm disorders in the United States [1]. Atrial fibrillation is of public health importance and profoundly increases morbidity, mortality, and health-related expenditures. Morbidities include outcomes such as heart failure, stroke and the deleterious effects on quality of life (QOL), functional status, and cognition. In the United States and Western Europe, the aging population and the accompanying rise in the prevalence of AF have magnified its toll on morbidity and healthcare costs.
Source: Trends in Cardiovascular Medicine - June 21, 2016 Category: Cardiology Authors: Amanulla Khaji, Peter R. Kowey Source Type: research

Evolving concepts in atrial fibrillation epidemiology: Advancing knowledge about cardiovascular health in sub-Saharan Africa
Atrial fibrillation (AF) is the most common cardiac arrhythmia presenting in the daily clinical practice [1]. In the last 50  years, AF prevalence and incidence have been shown to constantly increase, progressively becoming a worldwide healthcare issue, with relevant public health expenditure, both in terms of clinical management and consequences related to the main clinical adverse events related to AF (i.e. stroke, ma jor bleeding, cardiovascular events) [1,2].
Source: International Journal of Cardiology - July 4, 2018 Category: Cardiology Authors: Marco Proietti Tags: Editorial Source Type: research

Cardiac Rehabilitation and Secondary Prevention Roundtable: Australian Implementation and Research Priorities
Cardiovascular disease (CVD), including coronary heart disease (CHD) and stroke, is the leading cause of death and disease burden globally [1]. CVD resulted in>1.1 million hospitalisations in 2015-16, and incurs the highest level of health care sector expenditure in Australia (11-12% of total health expenditure) [2]. CHD accounts for the greatest single disease morbidity (>500,000 bed-days annually) and nearly one fifth of all deaths with a total cost of $1.14 billion annually [2]. Over 65,000 Australians experience an acute coronary event (heart attack or unstable angina) each year [3], and, importantly, around a third of...
Source: Heart, Lung and Circulation - February 28, 2020 Category: Cardiology Authors: Julie Redfern, Gemma Figtree, Clara Chow, Garry Jennings, Tom Briffa, Robyn Gallagher, Rachelle Foreman, on behalf of Roundtable Attendees Tags: Editorial Source Type: research

Comparison of Frequency of Atrial Fibrillation in Blacks versus Whites and the Utilization of Race in a Novel Risk Score
Atrial fibrillation (AF) is the most prevalent sustained arrhythmia in the world, with over 30 million people affected as of 2010.1 The number of patients projected to develop AF will double over the next decade.2 AF is independently associated with an increased risk of stroke,3 heart failure (HF),4 and mortality.5 It is not surprising, thus, that AF assumes a sizeable share of health care expenditure and its magnitude is reaching epidemic proportions.6 Blacks despite having a higher prevalence of traditional risk factors for AF, such as HF, hypertension, and diabetes mellitus, have been shown to have a lower incidence of AF.
Source: The American Journal of Cardiology - August 27, 2020 Category: Cardiology Authors: Gurukripa N. Kowlgi, Sampath Gunda, Santosh K. Padala, Jayanthi N. Koneru, Abhishek J. Deshmukh, Kenneth A. Ellenbogen Source Type: research

Endothelial Cell CD36 Reduces Atherosclerosis and Controls Systemic Metabolism
Front Cardiovasc Med. 2021 Nov 23;8:768481. doi: 10.3389/fcvm.2021.768481. eCollection 2021.ABSTRACTHigh-fat Western diets contribute to tissue dysregulation of fatty acid and glucose intake, resulting in obesity and insulin resistance and their sequelae, including atherosclerosis. New therapies are desperately needed to interrupt this epidemic. The significant idea driving this research is that the understudied regulation of fatty acid entry into tissues at the endothelial cell (EC) interface can provide novel therapeutic targets that will greatly modify health outcomes and advance health-related knowledge. Dysfunctional ...
Source: Atherosclerosis - December 10, 2021 Category: Cardiology Authors: Umar R Rekhi Mohamed Omar Maria Alexiou Cole Delyea Linnet Immaraj Shokrollah Elahi Maria Febbraio Source Type: research

Pyruvate Kinase M2: a novel regulator of adipogenesis
FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.L7944.ABSTRACTObesity is the cornerstone of many other conditions, with far-reaching impacts on numerous body systems and quality of life. Obesity is closely and likely causally associated with metabolic syndrome and consequent atherosclerosis, heart disease, stroke, and type 2 diabetes as well as diseases such as cancer and osteoarthritis. Recent studies suggest exploring the possibility of activating brown adipose tissue as a potential anti-obesity strategy. However, understanding the mechanisms underlying the processes of brown adipogenesis and browning is fou...
Source: Atherosclerosis - May 13, 2022 Category: Cardiology Authors: Presley D Dowker Jenna B Demeter Ahmed Bettaieb Source Type: research